ORTX insider filings
Orchard Therapeutics plc — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-01-24. Screen ORTX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ORTX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Orchard Therapeutics plc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-01-24 | 4 | Beck Joanne T. — Director | Disposition to issuer (D): 9,294 · Disposition to issuer (D): 46,000 (derivative) @ $0 · Disposition to issuer (D): 105,000 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Gaspar Bobby — Chief Executive Officer, Director | Disposition to issuer (D): 366,158 · Disposition to issuer (D): 597,860 (derivative) @ $0 · Disposition to issuer (D): 40,010 (derivative) @ $0 · Disposition to issuer (D): 96,420 (derivative) @ $0 · Disposition to issuer (D): 50,000 (derivative) @ $0 · Disposition to issuer (D): 200,000 (derivative) @ $0 · +7 more | EDGAR |
| 2024-01-24 | 4 | Dunoyer Marc — Director | Disposition to issuer (D): 37,179 · Disposition to issuer (D): 80,030 (derivative) @ $0 · Disposition to issuer (D): 46,000 (derivative) @ $0 · Disposition to issuer (D): 105,000 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Curnutte John T — Director | Disposition to issuer (D): 46,000 (derivative) @ $0 · Disposition to issuer (D): 105,000 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Rowland Charles A Jr — Director | Disposition to issuer (D): 12,294 · Disposition to issuer (D): 46,000 (derivative) @ $0 · Disposition to issuer (D): 105,000 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Altschuler Steven — Director | Disposition to issuer (D): 46,000 (derivative) @ $0 · Disposition to issuer (D): 105,000 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Secor Alicia — Director | Disposition to issuer (D): 46,000 (derivative) @ $0 · Disposition to issuer (D): 105,000 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | THOMAS FRANK E — See Remarks | Disposition to issuer (D): 92,081 · Disposition to issuer (D): 99,980 (derivative) @ $0 · Disposition to issuer (D): 199,990 (derivative) @ $0 · Disposition to issuer (D): 149,990 (derivative) @ $0 · Disposition to issuer (D): 309,990 (derivative) @ $0 · Disposition to issuer (D): 27,730 (derivative) @ $0 · +5 more | EDGAR |
| 2024-01-24 | 4 | GERAGHTY JAMES A — Director | Disposition to issuer (D): 44,391 · Disposition to issuer (D): 46,000 (derivative) @ $0 · Disposition to issuer (D): 105,000 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Dunoyer Marc — Director | Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Beck Joanne T. — Director | Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Secor Alicia — Director | Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Curnutte John T — Director | Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Altschuler Steven — Director | Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Rowland Charles A Jr — Director | Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | GERAGHTY JAMES A — Director | Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2023-03-14 | 4 | THOMAS FRANK E — See Remarks | Option exercise (M): 20,000 @ $0.46 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | Gaspar Bobby — Chief Executive Officer, Director | Grant/award (A): 563,410 (derivative) @ $0 · Grant/award (A): 581,590 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | THOMAS FRANK E — See Remarks | Grant/award (A): 405,600 (derivative) @ $0 · Grant/award (A): 179,400 (derivative) @ $0 | EDGAR |
| 2023-02-13 | 4 | THOMAS FRANK E — See Remarks | Option exercise (M): 20,000 @ $0.46 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2022-10-06 | 4 | Gaspar Bobby — Chief Executive Officer, Director | Disposition to issuer (D): 50,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 · Disposition to issuer (D): 200,000 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0 · Disposition to issuer (D): 300,000 (derivative) @ $0 · Grant/award (A): 300,000 (derivative) @ $0 · +4 more | EDGAR |
| 2022-10-06 | 4 | THOMAS FRANK E — See Remarks | Disposition to issuer (D): 426,185 (derivative) @ $0 · Grant/award (A): 426,185 (derivative) @ $0 · Disposition to issuer (D): 184,229 (derivative) @ $0 · Grant/award (A): 184,229 (derivative) @ $0 · Disposition to issuer (D): 100,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 · +10 more | EDGAR |
| 2022-06-08 | 4 | Beck Joanne T. — Director | Grant/award (A): 46,000 (derivative) @ $0 | EDGAR |
| 2022-06-08 | 4 | Dunoyer Marc — Director | Grant/award (A): 46,000 (derivative) @ $0 | EDGAR |
| 2022-06-08 | 4 | Secor Alicia — Director | Grant/award (A): 46,000 (derivative) @ $0 | EDGAR |
| 2022-06-08 | 4 | Curnutte John T — Director | Grant/award (A): 46,000 (derivative) @ $0 | EDGAR |
| 2022-06-08 | 4 | Altschuler Steven — Director | Grant/award (A): 46,000 (derivative) @ $0 | EDGAR |
| 2022-06-08 | 4 | Rowland Charles A Jr — Director | Grant/award (A): 46,000 (derivative) @ $0 | EDGAR |
| 2022-06-08 | 4 | GERAGHTY JAMES A — Director | Grant/award (A): 46,000 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | Gaspar Bobby — Chief Executive Officer, Director | Grant/award (A): 422,631 (derivative) @ $0 · Grant/award (A): 427,369 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | THOMAS FRANK E — See Remarks | Grant/award (A): 375,000 (derivative) @ $0 | EDGAR |
| 2022-04-05 | 4 | Gaspar Bobby — Chief Executive Officer, Director | Purchase (P): 15,000 @ $0.74 | EDGAR |
| 2022-04-04 | 4 | THOMAS FRANK E — See Remarks | Purchase (P): 10,000 @ $0.75 | EDGAR |
| 2021-06-17 | 4 | Dunoyer Marc — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Beck Joanne T. — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Secor Alicia — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Curnutte John T — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Altschuler Steven — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Rowland Charles A Jr — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | GERAGHTY JAMES A — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2021-03-10 | 4 | FMR LLC | Holdings only — no transactions reported | EDGAR |
| 2021-02-23 | 4 | FMR LLC — 10% owner | Conversion (C): 409,852 · Conversion (C): 409,852 · Conversion (C): 409,852 (derivative) · Conversion (C): 409,852 (derivative) | EDGAR |
| 2021-02-11 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 3,215,434 (derivative) @ $6.22 | EDGAR |
| 2021-02-10 | 4 | FMR LLC — 10% owner | Sale (S): 1,022,755 @ $6.98 · Sale (S): 1,022,755 @ $6.98 | EDGAR |
| 2021-02-03 | 4 | Gaspar Bobby — Chief Executive Officer, Director | Grant/award (A): 55,006 (derivative) @ $0 · Grant/award (A): 850,000 (derivative) @ $0 | EDGAR |
| 2021-02-03 | 4 | THOMAS FRANK E — See Remarks | Grant/award (A): 27,731 (derivative) @ $0 · Grant/award (A): 310,000 (derivative) @ $0 | EDGAR |
| 2021-02-01 | 4 | THOMAS FRANK E — See Remarks | Option exercise (M): 10,000 @ $2.44 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2021-01-12 | 4 | Gaspar Bobby — Chief Executive Officer, Director | Grant/award (A): 6,250 @ $0 · Tax withholding (F): 3,411 @ $6.72 | EDGAR |
| 2021-01-12 | 4 | THOMAS FRANK E — See Remarks | Grant/award (A): 10,667 @ $0 · Tax withholding (F): 3,706 @ $6.72 | EDGAR |
| 2020-11-06 | 4 | RA CAPITAL MANAGEMENT, L.P. — 10% owner RA Capital Healthcare Fund LP — 10% owner Kolchinsky Peter — 10% owner Shah Rajeev M. — 10% owner | Purchase (P): 14,570 @ $4.75 · Purchase (P): 6,787 @ $4.71 · Purchase (P): 16,291 @ $4.74 · Purchase (P): 13,031 @ $4.74 · Purchase (P): 8,235 @ $4.74 · Purchase (P): 45,249 @ $4.72 · +7 more | EDGAR |
Recent 8-K events — Orchard Therapeutics plc
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-01-24 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-22 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-12-19 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 8.01 — Other Events | EDGAR |
| 2023-12-08 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-11-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-21 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-26 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-05 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-09-18 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ORTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs